表紙
市場調查報告書

心臟安全性服務的全球市場 - 至2024年的預測:ECG/Holter檢測,血壓,心血管成像,TQT (Thorough QT) 檢驗

Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter Measurement, Blood Pressure, Cardiac Imaging, Thorough QT Study, Other Services), End User - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 917651
出版日期 內容資訊 英文 136 Pages
訂單完成後即時交付
價格
Back to Top
心臟安全性服務的全球市場 - 至2024年的預測:ECG/Holter檢測,血壓,心血管成像,TQT (Thorough QT) 檢驗 Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter Measurement, Blood Pressure, Cardiac Imaging, Thorough QT Study, Other Services), End User - Global Forecast to 2024
出版日期: 2019年11月27日內容資訊: 英文 136 Pages
簡介

心臟安全性服務市場預計將從2019年的4億4200萬美元,擴大到2024年7億5200萬美元。市場在2019年∼2024年間,預測將以年複合成長率 (CAGR) 11.2%的速度成長。

本報告提供全球心臟安全性服務市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 心臟安全性服務市場概要
  • 北美 - 心臟安全性服務市場:各終端用戶,各國
  • 心臟安全性服務市場:各地區的成長機會

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 機會
    • 課題

第6章 心臟安全性服務的全球市場:服務的各類型

  • 簡介
  • ECG/Holter檢測服務
  • 血壓檢測服務
  • 心血管成像服務
  • TQT (Thorough QT) 檢驗
  • 其他

第7章 心臟安全性服務的全球市場:各類型

  • 簡介
  • 整合型服務
  • 獨立型服務

第8章 心臟安全性服務的全球市場:各終端用戶

  • 簡介
  • 製藥、生物醫藥品企業
  • CRO (臨床研究委外機構)

第9章 心臟安全性服務的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭情形

  • 概要
  • 市場企業排行榜
  • 競爭情形、趨勢
  • 競爭領導製圖

第11章 企業簡介

  • BIOCLINICA (CINVEN的子公司)
  • LABCORP
  • BIOTELEMETRY, INC.
  • ERT, INC.
  • BANOOK GROUP
  • IQVIA
  • BIOTRIAL
  • CERTARA, L.P.
  • CELERION, INC.
  • MEDPACE
  • NCARDIA
  • RICHMOND PHARMACOLOGY
  • PHYSIOSTIM
  • SHANGHAI MEDICILON INC.
  • PHARMACEUTICAL PRODUCT DEVELOPMENT LLC
  • SGS S.A.

第12章 附錄

目錄
Product Code: PH 7455

"The cardiac safety services market is projected to register a CAGR of 11.2% during the forecast period."

The cardiac safety services market is projected to reach USD 752 million by 2024 from USD 442 million in 2019, at a CAGR of 11.2%. Growth in this industry is driven by the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increased outsourcing of R&D activities, and the increasing number of clinical trials. On the other hand, the high cost of cardiac safety evaluation is the burning issue in this market. In addition, the introduction of new technologies & methods and growth in the biosimilars and biologics market are offering growth opportunities for players in the market.

"The ECG/Holter measurement services segment is anticipated to grow at the fastest growth rate during the forecast period."

The cardiac safety services market based on the type of service is categorized into ECG/Holter measurement, blood pressure measurement, cardiovascular imaging, thorough QT studies, and other services. The ECG/Holter measurement segment is expected to register the highest CAGR during the forecast period. The low cost of ECG/Holter measurement services and their wide usage in measuring cardiac activity are the key factors driving the growth of this market.

"The integrated services segment is estimated to dominate the market during the analysis period."

By type, the cardiac safety services market is categorized into integrated and standalone services. The integrated services segment accounted for the largest share of the cardiac safety services market. The large share of this segment can be attributed to the benefits of bundled services to oversee end-to-end developments, as opposed to the specificity of standalone services. This helps reduce the time to market for manufacturers.

"The pharmaceutical & biopharmaceutical companies segment is estimated to grow at a rapid rate during the analysis period."

Based on end user, the cardiac safety services market is segmented into pharmaceutical & biopharmaceutical companies and CROs. The pharmaceutical & biopharmaceutical companies segment is expected to be the fastest-growing segment of the global cardiac safety services market during the forecast period. Factors such as the stringent regulations for drug safety and increasing R&D activities to develop new drugs are driving the growth of this segment.

"North America is estimated to register the highest CAGR during the study period."

Geographically, the cardiac safety services market was dominated by North America, followed by Europe in 2018. North Americ is estimated to grow at the fastest rate due to presence of major pharmaceutical & biopharmaceutical companies and the large number of clinical trials performed in the region.

Breakdown of Profiles of Primary Participants:

  • By Company Type: Tier 1: 20%, Tier 2: 45%, and Tier 3: 35%
  • By Designation: C-level: 30%, Director-level: 20%, and Others: 50%
  • By Region: North America: 35%, Europe: 24%, Asia Pacific: 25%, and the Rest of the World: 16%

Key players in the cardiac safety services market include: Biotrial (France), Banook Group (France & Canada), Bioclinica (US), Certara L.P. (US), Celerion, Inc. (US), ERT, Inc. (US), Laboratory Corporation of America Holdings (US), Medpace Holdings, Inc. (US), Ncardia AG (Belgium), Richmond Pharmacology (UK), PhysioStim (France), Shanghai Medicilon Inc. (China), SGS S.A. (Switzerland), BioTelemetry, Inc. (US), IQVIA (US), and Pharmaceutical Product Development LLC (US).

Research Coverage:

The report analyzes the cardiac safety services market by type of service, type, end user, and region. Apart from comprehensive geographic services analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the services portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding service offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use anyone, or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the services portfolios of the top players in the cardiac safety services market
  • Services Development/Innovation: Detailed insights on the R&D activities, and services launches, partnerships & agreements in the cardiac safety services market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and services portfolios of the leading players in the cardiac safety services market
  • Market Development: Detailed information about emerging markets. The report analyzes the market for various cardiac safety services across geographies
  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the cardiac safety services market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.2 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    • 2.2.3 GROWTH FORECAST
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CARDIAC SAFETY SERVICES MARKET OVERVIEW
  • 4.2 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY END USER & COUNTRY (2018)
  • 4.3 CARDIAC SAFETY SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry
      • 5.2.1.2 Increased outsourcing of R&D activities
      • 5.2.1.3 Increasing number of clinical trials
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Introduction of new technologies and methods
      • 5.2.2.2 Growth in the biosimilars and biologics markets
    • 5.2.3 CHALLENGES
      • 5.2.3.1 High cost of cardiac safety evaluation

6 CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE

  • 6.1 INTRODUCTION
  • 6.2 ECG/HOLTER MEASUREMENT SERVICES
    • 6.2.1 ECG/HOLTER MEASUREMENT SERVICES HELP IN THE R&D OF NOVEL METHODS FOR CLINICAL TRIALS AND DRUG DISCOVERY
  • 6.3 BLOOD PRESSURE MEASUREMENT SERVICES
    • 6.3.1 INCREASING R&D ACTIVITIES TO DRIVE THE GROWTH OF THE BLOOD PRESSURE MEASUREMENT SERVICES SEGMENT
  • 6.4 CARDIOVASCULAR IMAGING SERVICES
    • 6.4.1 CARDIOVASCULAR IMAGING SERVICES HELP IN DRUG EVALUATION
  • 6.5 THOROUGH QT STUDIES
    • 6.5.1 NEED TO MEET STRINGENT REGULATORY REQUIREMENTS IS DRIVING THE DEMAND FOR THOROUGH QT STUDIES
  • 6.6 OTHER SERVICES

7 CARDIAC SAFETY SERVICES MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 INTEGRATED SERVICES
    • 7.2.1 INTEGRATED SERVICES DOMINATE THE CARDIAC SAFETY SERVICES MARKET
  • 7.3 STANDALONE SERVICES
    • 7.3.1 STANDALONE SERVICES SEGMENT WITNESSING GROWTH DUE TO COST-EFFECTIVENESS

8 CARDIAC SAFETY SERVICES MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
    • 8.2.1 INCREASING R&D BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DRIVE THE DEMAND FOR CARDIAC SAFETY SERVICES
  • 8.3 CONTRACT RESEARCH ORGANIZATIONS
    • 8.3.1 INCREASING OUTSOURCING OF DRUG DISCOVERY PROCESSES TO SUPPORT THE GROWTH OF THIS END-USER SEGMENT

9 CARDIAC SAFETY SERVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 US dominates the global market for cardiac safety services
    • 9.2.2 CANADA
      • 9.2.2.1 Canada has high-quality clinical trial infrastructure and expertise
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Availability of skilled staff and flexible labor laws have made Germany a popular hub in the EU for clinical trials
    • 9.3.2 UK
      • 9.3.2.1 Steady growth of pharmaceutical R&D expenditure indicates favorable prospects for cardiac safety services
    • 9.3.3 FRANCE
      • 9.3.3.1 A large number of cancer therapy-focused clinical trials are conducted in France
    • 9.3.4 ITALY
      • 9.3.4.1 Italy's strong pharma industry and availability of funding for drug development have fueled market growth
    • 9.3.5 SPAIN
      • 9.3.5.1 Growing investment in pharmaceutical R&D and favorable climate for approvals are driving market growth
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
      • 9.4.1.1 China dominates the APAC market for cardiac safety services
    • 9.4.2 JAPAN
      • 9.4.2.1 Strong IP rights and supportive policies have strengthened the R&D sector in Japan
    • 9.4.3 INDIA
      • 9.4.3.1 Lack of language barriers and availability of trained resources make India an attractive destination for clinical trials
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Favorable R&D tax incentives and cash rebates have driven clinical trial activity in Australia
    • 9.4.5 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET PLAYER RANKING
  • 10.3 COMPETITIVE SITUATION AND TRENDS
    • 10.3.1 SERVICES LAUNCHES & UPGRADES
    • 10.3.2 EXPANSIONS
    • 10.3.3 ACQUISITIONS
    • 10.3.4 PARTNERSHIPS, ALLIANCES, AND AGREEMENTS
    • 10.3.5 OTHER STRATEGIES
  • 10.4 COMPETITIVE LEADERSHIP MAPPING - OVERALL MARKET (2019)
    • 10.4.1 VISIONARY LEADERS
    • 10.4.2 DYNAMIC DIFFERENTIATORS
    • 10.4.3 INNOVATORS
    • 10.4.4 EMERGING COMPANIES

11 COMPANY PROFILES

(Business Overview, Services Offered, Recent Developments, and MnM View)*

  • 11.1 BIOCLINICA (A SUBSIDIARY OF CINVEN)
  • 11.2 LABCORP
  • 11.3 BIOTELEMETRY, INC.
  • 11.4 ERT, INC.
  • 11.5 BANOOK GROUP
  • 11.6 IQVIA
  • 11.7 BIOTRIAL
  • 11.8 CERTARA, L.P.
  • 11.9 CELERION, INC.
  • 11.10 MEDPACE
  • 11.11 NCARDIA
  • 11.12 RICHMOND PHARMACOLOGY
  • 11.13 PHYSIOSTIM
  • 11.14 SHANGHAI MEDICILON INC.
  • 11.15 PHARMACEUTICAL PRODUCT DEVELOPMENT LLC
  • 11.16 SGS S.A.

Details on Business Overview, Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: R&D EXPENDITURE & PERCENTAGE CHANGE, BY COMPANY
  • TABLE 2: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 3: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4: NORTH AMERICA: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 5: EUROPE: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 6: ASIA PACIFIC: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 7: BLOOD PRESSURE MEASUREMENT SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: NORTH AMERICA: BLOOD PRESSURE MEASUREMENT SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 9: EUROPE: BLOOD PRESSURE MEASUREMENT SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 10: ASIA PACIFIC: BLOOD PRESSURE MEASUREMENT SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 11: CARDIOVASCULAR IMAGING SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: NORTH AMERICA: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 13: EUROPE: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 14: ASIA PACIFIC: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 15: THOROUGH QT STUDIES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: NORTH AMERICA: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17: EUROPE: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18: ASIA PACIFIC: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 19: OTHER CARDIAC SAFETY SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: NORTH AMERICA: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21: EUROPE: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22: ASIA PACIFIC: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 23: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 24: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: NORTH AMERICA: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 26: EUROPE: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27: ASIA PACIFIC: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 28: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: NORTH AMERICA: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 30: EUROPE: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31: ASIA PACIFIC: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 32: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 33: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 35: EUROPE: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 36: ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 37: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 38: NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39: EUROPE: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 40: ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 41: CARDIAC SAFETY SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 42: NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 43: NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 44: NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 45: NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 46: TOTAL NUMBER OF CLINICAL TRIALS IN THE US (TILL OCTOBER 2019)
  • TABLE 47: NUMBER OF CLINICAL TRIALS STARTED IN THE US, BY COMPANY, 2017
  • TABLE 48: US: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 49: US: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 50: US: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 51: NUMBER OF ACTIVE CLINICAL TRIALS IN CANADA, BY CONDITION (2019)
  • TABLE 52: NUMBER OF ACTIVE CLINICAL TRIALS IN CANADA, BY COMPANY, 2017
  • TABLE 53: CANADA: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 54: CANADA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55: CANADA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 56: EUROPE: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 57: EUROPE: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 58: EUROPE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 59: EUROPE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 60: GERMANY: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 61: GERMANY: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 62: GERMANY: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 63: UK: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 64: UK: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 65: UK: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 66: NUMBER OF CLINICAL TRIALS STARTED IN FRANCE, BY COMPANY, 2017
  • TABLE 67: FRANCE: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 68: FRANCE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 69: FRANCE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 70: NUMBER OF CLINICAL TRIALS STARTED IN ITALY, BY COMPANY, 2017
  • TABLE 71: ITALY: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 72: ITALY: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 73: ITALY: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 74: SPAIN: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 75: SPAIN: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 76: SPAIN: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 77: ROE: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 78: ROE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 79: ROE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 80: CLINICAL TRIALS IN THE ASIA PACIFIC, BY THERAPEUTIC AREA, 2017
  • TABLE 81: APAC: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 82: APAC: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 83: APAC: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: APAC: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 85: CHINA: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 86: CHINA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 87: CHINA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 88: JAPAN: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 89: JAPAN: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 90: JAPAN: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 91: INDIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 92: INDIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 93: INDIA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 94: AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 95: AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 96: AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 97: ROAPAC: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 98: ROAPAC: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 99: ROAPAC: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 100: ROW: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2017-2024 (USD MILLION)
  • TABLE 101: ROW: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 102: ROW: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 103: GLOBAL CARDIAC SAFETY SERVICES MARKET PLAYER RANKING, 2018
  • TABLE 104: SERVICE LAUNCHES & UPGRADES, 2016-2019
  • TABLE 105: EXPANSIONS, 2016-2019
  • TABLE 106: ACQUISITIONS, 2016-2019
  • TABLE 107: PARTNERSHIPS, ALLIANCES, AND AGREEMENTS, 2016-2019
  • TABLE 108: OTHER STRATEGIES, 2016- 2019

LIST OF FIGURES

  • FIGURE 1: CARDIAC SAFETY SERVICES MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: CARDIAC SAFETY SERVICES MARKET, BY TYPE OF SERVICE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: CARDIAC SAFETY SERVICES MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: INCREASING R&D EXPENDITURE IN THE PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY TO DRIVE MARKET GROWTH
  • FIGURE 12: PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES WERE THE LARGEST END USERS OF CARDIAC SAFETY SERVICES IN THE NORTH AMERICAN MARKET IN 2018
  • FIGURE 13: THE US TO REGISTER THE HIGHEST GROWTH IN THE CARDIAC SAFETY SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 14: CARDIAC SAFETY SERVICES MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: ACTIVE PHARMACEUTICAL PIPELINE, JANUARY 2009 TO JANUARY 2019
  • FIGURE 16: TOTAL NUMBER OF REGISTERED STUDIES (2005-2017)
  • FIGURE 17: TRIAL COUNT BY PHASE & THERAPEUTIC AREA, 2017
  • FIGURE 18: R&D SPENDING OF PHRMA MEMBER COMPANIES (USD BILLION)
  • FIGURE 19: TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (OCTOBER 2019)
  • FIGURE 20: NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET SNAPSHOT
  • FIGURE 21: UK: PHARMACEUTICAL R&D EXPENDITURE, 2013-2017
  • FIGURE 22: SPAIN: PHARMACEUTICAL R&D EXPENDITURE, 2011-2017
  • FIGURE 23: CLINICAL TRIAL PENETRATION: DEVELOPED VS. DEVELOPING COUNTRIES, 2016
  • FIGURE 24: ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET SNAPSHOT
  • FIGURE 25: SERVICE LAUNCH AND UPGRADATION-KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2016 TO 2019
  • FIGURE 26: COMPETITIVE LEADERSHIP MAPPING OF THE CARDIAC SAFETY SERVICES MARKET
  • FIGURE 27: LABCORP: COMPANY SNAPSHOT
  • FIGURE 28: BIOTELEMETRY: COMPANY SNAPSHOT
  • FIGURE 29: IQVIA: COMPANY SNAPSHOT
  • FIGURE 30: MEDPACE: COMPANY SNAPSHOT
  • FIGURE 31: NCARDIA: COMPANY SNAPSHOT
  • FIGURE 32: SGS S.A.: COMPANY SNAPSHOT
Back to Top